Calcium Metabolism in the Morbidly Obese

Abstract

Morbidly obese patients are known to have abnormal calcium metabolism compared with the non-obese, but the clinical significance of this is unknown. Since surgical treatment of obesity may itself cause hyperparathyroidism, it is important to understand the preoperative physiology of these patients. 213 consecutive patients (M 37 : F 176, ages 21-68) presenting for surgical treatment of morbid obesity between October 2000 and June 2002 were prospectively evaluated. Preoperative levels of serum calcium corrected for albumin, alkaline phosphatase, parathyroid hormone (PTH), 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D were measured. We recorded the prevalence of abnormalities in study parameters and correlated them with PTH levels. Hyperparathyroidism (PTH >65 pg/ml) was present in 25.0% of subjects. By contrast, abnormalities of serum calcium were rare. The prevalence of hypocalcemia was 3.5%, and of hypercalcemia was 0.5%. Only 4.3% of patients had increased levels of alkaline phosphatase. 21.1% of patients had abnormally low levels of 25-hydroxyvitamin D (median 15 ng/ml), and 23.1% had increased levels of 1,25-dihydroxyvitamin D (median 49 pg/ml). PTH was positively correlated with BMI (r=.30, P=<.001) and 25-dihydroxyvitamin D (r=.27, P=.01), and was negatively correlated with alkaline phosphatase (r=.21, P=.02). There was no correlation between PTH and calcium, 1,25-dihydoxyvitamin D, age, or sex. Parathyroid hormone levels are increased in the morbidly obese and are positively correlated with BMI. Recognition of preoperative hyperparathyroidism is important because of the risk of attributing postoperative hyperparathyroidism to the effects of surgery. Further studies are needed to elucidate the cause of elevated PTH in these patients.